These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37511546)
1. α5-GABAA Receptor Modulation Reverses Behavioral and Neurophysiological Correlates of Psychosis in Rats with Ventral Hippocampal Alzheimer's Disease-like Pathology. Eassa NE; Perez SM; Boley AM; Elam HB; Sharmin D; Cook JM; Lodge DJ Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511546 [TBL] [Abstract][Full Text] [Related]
2. Positive Allosteric Modulation of α5-GABAA Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle. McCoy AM; Prevot TD; Mian MY; Cook JM; Frazer A; Sibille EL; Carreno FR; Lodge DJ Int J Neuropsychopharmacol; 2022 Aug; 25(8):688-698. PubMed ID: 35732272 [TBL] [Abstract][Full Text] [Related]
3. Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer's Disease. Perez SM; Boley AM; McCoy AM; Lodge DJ Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108357 [TBL] [Abstract][Full Text] [Related]
6. GL-II-73, a Positive Allosteric Modulator of α5GABA McCoy AM; Prevot TD; Sharmin D; Cook JM; Sibille EL; Lodge DJ Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511346 [TBL] [Abstract][Full Text] [Related]
7. Positive and Negative Selective Allosteric Modulators of α5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease. Aranđelović J; Santrač A; Batinić B; Todorović L; Ahmed Khan MZ; Rashid F; Poe MM; Obradović A; Cook JM; Savić MM J Alzheimers Dis; 2021; 84(3):1291-1302. PubMed ID: 34657887 [TBL] [Abstract][Full Text] [Related]
8. Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat. Perez SM; Donegan JJ; Boley AM; Aguilar DD; Giuffrida A; Lodge DJ Schizophr Res; 2019 Apr; 206():263-270. PubMed ID: 30522798 [TBL] [Abstract][Full Text] [Related]
9. Extrasynaptic localization is essential for α5GABA McCoy AM; Prevot TD; Mian MY; Sharmin D; Ahmad AN; Cook JM; Sibille EL; Lodge DJ bioRxiv; 2023 Jul; ():. PubMed ID: 37502875 [TBL] [Abstract][Full Text] [Related]
10. Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis. Sweet RA; Hamilton RL; Healy MT; Wisniewski SR; Henteleff R; Pollock BG; Lewis DA; DeKosky ST Arch Neurol; 2001 Mar; 58(3):466-72. PubMed ID: 11255451 [TBL] [Abstract][Full Text] [Related]
11. Α2 GABAA receptor sub-units in the ventral hippocampus and α5 GABAA receptor sub-units in the dorsal hippocampus mediate anxiety and fear memory. McEown K; Treit D Neuroscience; 2013 Nov; 252():169-77. PubMed ID: 23962649 [TBL] [Abstract][Full Text] [Related]
12. Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease. Price DL; Bonhaus DW; McFarland K Behav Pharmacol; 2012 Aug; 23(4):426-33. PubMed ID: 22750845 [TBL] [Abstract][Full Text] [Related]
13. Selective Modulation of α5 GABA Petrache AL; Khan AA; Nicholson MW; Monaco A; Kuta-Siejkowska M; Haider S; Hilton S; Jovanovic JN; Ali AB Front Cell Neurosci; 2020; 14():568194. PubMed ID: 33262690 [TBL] [Abstract][Full Text] [Related]
14. Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease. Bazzigaluppi P; Beckett TL; Koletar MM; Lai AY; Joo IL; Brown ME; Carlen PL; McLaurin J; Stefanovic B J Neurochem; 2018 Mar; 144(5):669-679. PubMed ID: 28777881 [TBL] [Abstract][Full Text] [Related]
15. A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. Gill KM; Lodge DJ; Cook JM; Aras S; Grace AA Neuropsychopharmacology; 2011 Aug; 36(9):1903-11. PubMed ID: 21562483 [TBL] [Abstract][Full Text] [Related]
16. Aripiprazole in the treatment of Alzheimer's disease. De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964 [TBL] [Abstract][Full Text] [Related]
17. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice. Hu L; Wong TP; Côté SL; Bell KF; Cuello AC Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000 [TBL] [Abstract][Full Text] [Related]